5-10 November 2017
Venice (Venezia), Italy
Europe/Rome timezone

Scientific Secretariat:

Roberto Cherubini
INFN-Laboratori Nazionali di  Legnaro,Legnaro-Padova, Italy

Francis A. Cucinotta
Department of Health Physics and Diagnostic Sciences, University of Nevada, Las Vegas, NV, USA

Peter O'Neill
Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK


 

Scientific Committee:

K. Ando, Gunma University, Maebashi, Japan
E. Azzam, UMDNJ – New Jersey Medical School, Newark, USA
M. Barcellos-Hoff, University of California, San Francisco, School of Medicine, San Francisco, USA
V. Bashkirov, School of Medicine, Loma Linda University,Loma Linda, Ca, USA
M. Belli, Istituto Superiore di Sanità and INFN, Rome, Italy
L. Braby, Texas A&M University, College Station, USA
M. Davidkova,Nucl Phys Inst CAS, Dept Radiat Dosimetry, Czech Republic
J.F. Dicello, Johns Hopkins University School of Medicine, USA
M. Dingfelder, East Carolina University, Greenville, USA
M. Durante, TIFPA-INFN , Trento, Italy
D. Emfietzoglou, Univ Ioannina, Sch Med, Med Phys Lab, Ioannina, Greece
D.T. Goodhead, MRC, Harwell, UK
M. Hill, Oxford Institute for Radiation Biology, UK
R. Howell, UMDNJ – New Jersey Medical School, Newark, USA
G. Iliakis, Universität Duisburg-Essen, Germany
H. G. Menzel, ICRP and ICRU - Switzerland
P. Olko, Institute of Nuclear Physics PAN, Krakow, Poland
J.P Pouget , Institut de Recherche en Cancérologie de Montpellier, Montpellier, France
K.M. Prise, Centre for Cancer Research & Cell Biology, Queen's University Belfast, Belfast, UK
A. Rosenfeld, University of Wollongong, Australia
L. Sabatier, CEA, Fontenay-aux-Roses, France
T. Sato,  Japan Atomic Energy Agency , Japan
B. Stenerlow, Uppsala University, Uppsala, Sweden
A.J. Waker, University of Ontario Institute of Technology, Oshawa, Canada
M. Waligorski, Centrum Onkologii Oddzial, Krakow, Poland
M. Weinfeld, Cross Cancer Institute, Edmonton, Canada
A. Yokoya, Japan Atom Energy Agency, Japan
G. Zhou, Soochow University, Suzhou, China